This opportunity is no longer accepting applications.
grant PAR-23-125

Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)

The Avenir Award Program supports early stage investigators conducting innovative research on substance abuse and HIV/AIDS. It targets studies that align with NIH HIV/AIDS research priorities, focusing on the connection between drug abuse and HIV/AIDS. The program funds both basic and clinical research that could reduce HIV incidence, improve HIV therapies, mitigate comorbid conditions, and ai…

Avenir means future in French, and the Avenir Award Program for Research on Substance Abuse and HIV/AIDS looks toward the future by supporting early stage investigators (ESI) proposing highly innovative studies that address NIH HIV/AIDS Research Priorities https://grants.nih.gov/grants/guide/no…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse

Dates

Opportunity Released: March 10, 2023
Open for Submission: March 10, 2023
Submission Deadline: August 15, 2025
Application Window Closes: August 15, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.